TABLE OF CONTENTS
Volume 11, Issue 3 (March 2004)
Original Articles
Chemokine gene modification of human dendritic cell-based tumor vaccines using a recombinant adenoviral vector FREE
Alicia Terando, Blake Roessler and James J Mulé
Cancer Gene Ther 11: 165-173; advance online publication, January 16, 2004; doi:10.1038/sj.cgt.7700671
Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity FREE
John Irving, Zhuo Wang, Sandra Powell, Chris O'Sullivan, Michael Mok, Brian Murphy, Lisa Cardoza, Jane S Lebkowski and Anish S Majumdar
Cancer Gene Ther 11: 174-185; advance online publication, January 16, 2004; doi:10.1038/sj.cgt.7700666
Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53 FREE
Matthias Kappler, Matthias Bache, Frank Bartel, Matthias Kotzsch, Matti Panian, Peter Würl, Karen Blümke, Hannelore Schmidt, Axel Meye and Helge Taubert
Cancer Gene Ther 11: 186-193; advance online publication, January 23, 2004; doi:10.1038/sj.cgt.7700677
Treatment of bladder carcinomas using recombinant BCG DNA vaccines and electroporative gene immunotherapy FREE
Chi-Feng Lee, Sun-Yran Chang, Dar-Shih Hsieh and Dah-Shyong Yu
Cancer Gene Ther 11: 194-207; doi:10.1038/sj.cgt.7700658
Comparison of different methods to assess the cytotoxic effects of cytosine deaminase and thymidine kinase gene therapy FREE
Heike Corban-Wilhelm, Volker Ehemann, Gabriele Becker, Ditmar Greulich, Klaus Braun and Jürgen Debus
Cancer Gene Ther 11: 208-214; advance online publication, December 12, 2003; doi:10.1038/sj.cgt.7700667
Role of 4-1BB:4-1BB ligand in cancer immunotherapy FREE
Adam T C Cheuk, Ghulam J Mufti and Barbara-ann Guinn
Cancer Gene Ther 11: 215-226; advance online publication, December 12, 2003; doi:10.1038/sj.cgt.7700670
Induction of CAMEL/NY-ESO-ORF2-specific CD8+ T cells upon stimulation with dendritic cells infected with a modified Ad5 vector expressing a chimeric Ad5/35 fiber FREE
Elisabeth H Slager, Caroline E van der Minne, Jaap Goudsmit, Johanna M M van Oers, Stefan Kostense, Menzo J E Havenga, Susanne Osanto and Marieke Griffioen
Cancer Gene Ther 11: 227-236; advance online publication, January 16, 2004; doi:10.1038/sj.cgt.7700674
In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL FREE
Sung-Hyung Lee, Erez Bar-Haim, Arthur Machlenkin, Ofir Goldberger, Ilan Volovitz, Ezra Vadai, Esther Tzehoval and Lea Eisenbach
Cancer Gene Ther 11: 237-248; advance online publication, January 23, 2004; doi:10.1038/sj.cgt.7700678
